Supply of MMR Vaccines 2026 – 2030

Notice title: Rammekontrakt om levering af MFR-vaccine 2026 – 2030

Supply of MMR vaccines (measles, mumps, rubella vaccines): for the period 2026 – 2030 for the public vaccination program. The offered vaccine must have a marketing authorization valid for Denmark at the time of tender submission, in accordance with § 7, para. 1 of the Danish Medicines Act. The estimated annual requirement is approximately 130,000 – 150,000 doses, corresponding to an estimated total quantity of approximately 520,000 – 600,000 doses over the contract duration. The maximum purchase quantity is up to 750,000 doses over the contract term of up to 48 months.

Tender documents

Additional details